JPRN-UMIN000002805招募中2 期
Phase II study of irinotecan in patients with chemotherapy pretreated angiosarcoma. The ANGIRI study. - Phase II study for angiosarcoma
Masashi Ando0 个研究点目标入组 18 人开始时间: 2010年1月10日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 18
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Expected women 2. patients withj active infection 3. patients with interstitial pneumonia 4. patients with symptomatic brain metastasis 5. HIV positive patients
研究者
相似试验
已完成
2 期
Phase II study of irinotecan in patients with chemotherapy pretreated angiosarcoma.angiosarcomaJPRN-UMIN000008187ational Cancer Center Hospital18
进行中（未招募）
1 期
Clinical study of irinotecan weekly in patients with locally advanced or metastatic HER2-negative breast cancer and increased cancer cell copy number of the topoisomerase 1 gene”MedDRA version: 17.1Level: LLTClassification code 10027475Term: Metastatic breast cancerSystem Organ Class: 100000004864Metastatic breast cancerEUCTR2012-002348-26-DKDanish Breast Cancer Group (BDCG)40
招募中
2 期
Efficacy and safety of irinotecan after chemotherapy in combination with immunotherapy in patients with extensive stage small cell lung cancer: a phase II trialExtensive stage small cell lung cancerJPRN-UMIN000042892Third department of internal medicine, Universtiy of Fukui22
已完成
不适用
A phase 2 neoadjuvant chemotherapy of Irinotecan (CPT-11) plus Nedaplatin (NDP) for stage 1b2 or 2 cervical cancer of the uterine cervixstage 1b2/2 cervical cancerJPRN-UMIN000000552Japanese Gynecologic Oncology Group65
已完成
1 期
A phase I/II study of chemotherapy using Irinotecan, S-1 plus Oxaliplatin (IRISOX therapy) for unresectable pancreatic cancerJPRN-UMIN000016945Department of Gastroenterology Kitasato University School of Medicine25